to Advance Efforts
The Cure Sickle Cell Initiative builds upon research that long has been taking place in the government and private sector. We are engaging researchers in all scientific disciplines—those currently working in sickle cell disease and those working outside of the disease area—to help us accelerate the development and testing of treatments aimed at genetic based cures.
The NHLBI’s Investment
The Initiative complements the National Heart, Lung, and Blood Institute (NHLBI)’s investment in sickle cell disease research, which includes basic, clinical, translational, and implementation science research. The Cure Sickle Cell Initiative does not replace ongoing research efforts; rather, it complements them. The NHLBI continues to fund research conducted by investigators focusing on sickle cell disease, and this Initiative helps fill gaps that cannot be covered by traditional funding methods.
In addition to providing traditional funding, the Initiative also connects researchers to technical assistance, expertise and access to scientific information and resources to which researchers might not otherwise have immediate access.